Journal article

Workshop report: Malaria vaccine development in Europe-preparing for the future.

Abstract:: The deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. With the launch of the 2030 Malaria Vaccine Technology Roadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. During a workshop in Brussels in November 2014, hosted by the European Vaccine Initiative, key players from the European, North American and African malaria vaccine community discussed European strategies for future malaria vaccine development in the global context. The recommendations of the European malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated Malaria Vaccine Technology Roadmap.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Viebig, N., D'Alessio, F., Draper, S., Sim, B., Mordmüller, B., Bowyer, P., Luty, A., Jungbluth, S., Chitnis, C., Hill, A., Kremsner, P., Craig, A., Kocken, C., & Leroy, O. (2015). Workshop report: Malaria vaccine development in Europe-preparing for the future. Vaccine, 33(46), 6137–6144.

MLA Style

Viebig, N, et al. “Workshop Report: Malaria Vaccine Development in Europe-Preparing for the Future.” Vaccine, vol. 33, no. 46, 2015, pp. 6137–44.

Chicago Style

Viebig, N, F D'Alessio, S Draper, et al. 2015. “Workshop Report: Malaria Vaccine Development in Europe-Preparing for the Future.” Vaccine 33 (46): 6137–44.
Print

Access Document

Publisher copy:: 10.1016/j.vaccine.2015.09.074

Authors

+ Viebig, N More by this author

Role:: Author

+ D'Alessio, F More by this author

Role:: Author

+ Draper, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDM
Sub department:: Jenner Institute
Role:: Author

+ Sim, B More by this author

Role:: Author

+ Mordmüller, B More by this author

Role:: Author

More authors...

Publisher:: Elsevier
Journal:: Vaccine More from this journal
Volume:: 33
Issue:: 46
Pages:: 6137-6144
Publication date:: 2015-10-01
DOI:: 10.1016/j.vaccine.2015.09.074
EISSN:: 1873-2518
ISSN:: 0264-410X

Language:: English
Keywords:: Correlates of protection

Malaria

Controlled human malaria infection

Capacity building

Antigen discovery

Vaccine
Pubs id:: pubs:575198
UUID:: uuid:5ab39689-85a7-4d57-b110-eb9f3d58f9ad
Local pid:: pubs:575198
Source identifiers:: 575198
Deposit date:: 2016-01-06
ARK identifier:: ark:/29072/ora_5ab3968985a74d57b110eb9f3d58f9ad

Terms of use

Copyright holder:: Elsevier
Copyright date:: 2015
Notes:: © 2015 Elsevier Inc. All rights reserved.This is the accepted manuscript version of the article. The final version is available online from Elsevier at: [10.1016/j.vaccine.2015.09.074]

Licence:: CC Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP